HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott recalls infant formula

This article was originally published in The Tan Sheet

Executive Summary

Abbott's Ross Products Division announces Sept. 15 it is voluntarily recalling some lots of liquid ready-to-feed infant formula distributed between May 18 and Sept. 5. One lot of Similac Alimentum Advance liquid ready-to-feed infant formula, use by May 1, 2007; two lots of Similac Advance with Iron liquid ready-to-feed infant formula, use by Nov. 1, 2007; and one lot of Similac Advance Hospital Discharge Kits are all being recalled due to an isolated bottle defect the release states. An Abbott spokesperson said some of the bottles are missing a layer that prevents air from getting to the formula and thus may lead the vitamin C to oxidize, or breakdown. If consumers have the listed products they should contact Abbott at 1-800-624-3412. Abbott discovered the problem as a result of consumer complaints for an unusually dark formula color the release states...

You may also be interested in...

Abbott Recalls Infant Formula Made At Facility FDA Is Investigating For Bacterial Contamination

Abbott Labs recalls Similac, Alimentum and EleCare brand formula powders made at Sturgis, MI, plant. FDA says complaints about Abbott’s formulas included three reports of Cronobacter sakazakii infections, with one death potentially linked, and one of Salmonella Newport infection.

Over the Counter 29 June 2022: OTC Birth Control In The Wake Of The US Supreme Court Decision With Victoria Nichols

In this episode, HBW Insight speaks to Victoria Nichols, project director of Free the Pill, a campaign supporting increased OTC oral contraceptive access in the US. In the wake of the Supreme Court’s decision to overturn Roe v. Wade on 24 June, Nichols discusses the importance of advocating for OTC birth control, the limited availability of OTC oral contraceptives in the US, and the current legislation being introduced that would help ensure OTC birth control is covered by insurance. 

Novartis To Cut 8,000 Jobs In Global Restructure

CEO Vas Narasimhan wants the company to be more agile and identify more blockbuster opportunities.


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts